• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

5α-还原酶系统及其抑制剂。治疗雄激素依赖性皮肤疾病的最新进展及其前景。

The 5 alpha-reductase system and its inhibitors. Recent development and its perspective in treating androgen-dependent skin disorders.

作者信息

Chen W, Zouboulis C C, Orfanos C E

机构信息

Department of Dermatology, University Medical Center Benjamin Franklin, Free University of Berlin, Germany.

出版信息

Dermatology. 1996;193(3):177-84. doi: 10.1159/000246242.

DOI:10.1159/000246242
PMID:8944337
Abstract

5 alpha-Reductase, the enzyme system that metabolizes testosterone into dihydrotestosterone, occurs in two isoforms. The type 1 isozyme is composed of 259 amino acids, has an optimal pH of 6-9 and represents the 'cutaneous type'; it is located mainly in sebocytes but also in epidermal and follicular keratinocytes, dermal papilla cells and sweat glands as well as in fibroblasts from genital and non-genital skin. The type 2 isozyme is composed of 254 amino acids, has an optimal pH of about 5.5 and is located mainly in the epididymis, seminal vesicles, prostate and fetal genital skin as well as in the inner root sheath of the hair follicle and in fibroblasts from normal adult genital skin. The genes encoding type 1 and type 2 isozymes are found in chromosomes 5p and 2p, respectively, and each consists of 5 exons and 4 introns. During the last decade, several steroid analogues and non-steroid agents have been developed to interfere with 5 alpha-reductase activity. Finasteride, which has a higher affinity for the type 2 isozyme, is the first 5 alpha-reductase antagonist clinically introduced for treatment of benign prostate hyperplasia. The clinical evaluation of finasteride or other 5 alpha-reductase inhibitors in the field of dermatology has been very limited; in particular, those that selectively bind to type 1 isozyme (e.g. MK-386, LY191704) may be regarded as candidates for treatment of androgen-dependent skin disorders such as seborrhoea, acne, hirsutism and/or androgenetic alopecia.

摘要

5α-还原酶是一种将睾酮代谢为二氢睾酮的酶系统,它有两种同工型。1型同工酶由259个氨基酸组成,最适pH值为6 - 9,代表“皮肤型”;它主要位于皮脂腺细胞中,但也存在于表皮和毛囊角质形成细胞、真皮乳头细胞和汗腺以及生殖器和非生殖器皮肤的成纤维细胞中。2型同工酶由254个氨基酸组成,最适pH值约为5.5,主要位于附睾、精囊、前列腺和胎儿生殖器皮肤以及毛囊内根鞘和正常成年生殖器皮肤的成纤维细胞中。编码1型和2型同工酶的基因分别位于5号染色体短臂和2号染色体短臂上,每个基因都由5个外显子和4个内含子组成。在过去十年中,已经开发出几种类固醇类似物和非类固醇药物来干扰5α-还原酶的活性。非那雄胺对2型同工酶具有更高的亲和力,是临床上首个用于治疗良性前列腺增生的5α-还原酶拮抗剂。非那雄胺或其他5α-还原酶抑制剂在皮肤病学领域的临床评估非常有限;特别是那些选择性结合1型同工酶的药物(如MK - 386、LY191704)可被视为治疗雄激素依赖性皮肤病如脂溢性皮炎、痤疮、多毛症和/或雄激素性脱发的候选药物。

相似文献

1
The 5 alpha-reductase system and its inhibitors. Recent development and its perspective in treating androgen-dependent skin disorders.5α-还原酶系统及其抑制剂。治疗雄激素依赖性皮肤疾病的最新进展及其前景。
Dermatology. 1996;193(3):177-84. doi: 10.1159/000246242.
2
Activity of type 1 5 alpha-reductase is greater in the follicular infrainfundibulum compared with the epidermis.与表皮相比,毛囊漏斗部的1型5α-还原酶活性更高。
Br J Dermatol. 1997 Feb;136(2):166-71.
3
Finasteride inhibits 5 alpha-reductase activity in human dermal fibroblasts: prediction of its therapeutic application in androgen-related skin diseases.非那雄胺抑制人皮肤成纤维细胞中的5α-还原酶活性:预测其在雄激素相关皮肤病中的治疗应用。
Int J Dermatol. 1995 Oct;34(10):720-5. doi: 10.1111/j.1365-4362.1995.tb04663.x.
4
Role of 5α-reductase inhibitors in androgen-stimulated skin disorders.5α-还原酶抑制剂在雄激素刺激的皮肤疾病中的作用。
J Drugs Dermatol. 2013 Feb;12(2):e30-5.
5
Localization by in situ hybridization of steroid 5alpha-reductase isozyme gene expression in the human prostate and preputial skin.人前列腺和包皮皮肤中类固醇5α-还原酶同工酶基因表达的原位杂交定位
J Urol. 1998 Aug;160(2):577-82.
6
[Finasteride: a new drug for the treatment of male hirsutism and androgenetic alopecia?].非那雄胺:一种治疗男性多毛症和雄激素性脱发的新药?
Clin Ter. 1996 Jun;147(6):305-15.
7
Characterization, expression, and immunohistochemical localization of 5 alpha-reductase in human skin.
J Invest Dermatol. 1994 Feb;102(2):221-6. doi: 10.1111/1523-1747.ep12371766.
8
5alpha-reductase activity in the prostate.前列腺中的5α-还原酶活性
Urology. 2001 Dec;58(6 Suppl 1):17-24; discussion 24. doi: 10.1016/s0090-4295(01)01299-7.
9
Is increased 5 alpha-reductase activity a primary phenomenon in androgen-dependent skin disorders?5α-还原酶活性增加是雄激素依赖性皮肤疾病的主要现象吗?
J Invest Dermatol. 1987 Jul;89(1):87-92. doi: 10.1111/1523-1747.ep12580432.
10
Dihydrotestosterone and the concept of 5alpha-reductase inhibition in human benign prostatic hyperplasia.双氢睾酮与人类良性前列腺增生中5α-还原酶抑制的概念
Eur Urol. 2000 Apr;37(4):367-80. doi: 10.1159/000020181.

引用本文的文献

1
Efficacy and Safety of Low-Dose (0.2 mg) Dutasteride for Male Androgenic Alopecia: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Phase III Clinical Trial.低剂量(0.2毫克)度他雄胺治疗男性雄激素性脱发的疗效和安全性:一项多中心、随机、双盲、安慰剂对照、平行组III期临床试验。
Ann Dermatol. 2025 Aug;37(4):183-190. doi: 10.5021/ad.25.048.
2
Insulin Resistance and Acne: The Role of Metformin as Alternative Therapy in Men.胰岛素抵抗与痤疮:二甲双胍作为男性替代疗法的作用。
Pharmaceuticals (Basel). 2022 Dec 26;16(1):27. doi: 10.3390/ph16010027.
3
Genital Wound Repair and Scarring.
生殖器创伤修复与瘢痕形成。
Med Sci (Basel). 2022 Apr 18;10(2):23. doi: 10.3390/medsci10020023.
4
Efficacy of Intralesional and Oral Dutasteride in the Treatment of Androgenetic Alopecia: A Systematic Review.病灶内注射与口服度他雄胺治疗雄激素性脱发的疗效:一项系统评价
Skin Appendage Disord. 2020 Nov;6(6):338-345. doi: 10.1159/000510697. Epub 2020 Oct 9.
5
Functional complexity of hair follicle stem cell niche and therapeutic targeting of niche dysfunction for hair regeneration.毛囊干细胞龛的功能复杂性及通过靶向干预毛囊龛功能实现毛发生长的治疗策略。
J Biomed Sci. 2020 Mar 14;27(1):43. doi: 10.1186/s12929-020-0624-8.
6
Development of finasteride polymer microspheres for systemic application in androgenic alopecia.用于雄激素性脱发系统应用的非那雄胺聚合物微球的研制。
Int J Mol Med. 2019 Jun;43(6):2409-2419. doi: 10.3892/ijmm.2019.4149. Epub 2019 Mar 28.
7
Identification of a new plant extract for androgenic alopecia treatment using a non-radioactive human hair dermal papilla cell-based assay.使用基于非放射性人毛发真皮乳头细胞的检测方法鉴定一种用于治疗雄激素性脱发的新型植物提取物。
BMC Complement Altern Med. 2016 Jan 21;16:18. doi: 10.1186/s12906-016-1004-5.
8
Avicequinone C isolated from Avicennia marina exhibits 5α-reductase-type 1 inhibitory activity using an androgenic alopecia relevant cell-based assay system.从白骨壤中分离出的阿魏醌C,在一个与雄激素性脱发相关的细胞检测系统中,表现出1型5α-还原酶抑制活性。
Molecules. 2014 May 23;19(5):6809-21. doi: 10.3390/molecules19056809.
9
Evaluation of the Quantitative and Qualitative Alterations in the Fatty Acid Contents of the Sebum of Patients with Inflammatory Acne during Treatment with Systemic Lymecycline and/or Oral Fatty Acid Supplementation.全身性赖甲环素治疗和/或口服脂肪酸补充剂治疗期间炎性痤疮患者皮脂中脂肪酸含量的定量和定性变化评估
Dermatol Res Pract. 2013;2013:120475. doi: 10.1155/2013/120475. Epub 2013 Sep 26.
10
Metabolism of BYZX in human liver microsomes and cytosol: identification of the metabolites and metabolic pathways of BYZX.BYZX 在人肝微粒体和胞浆中的代谢:鉴定 BYZX 的代谢产物和代谢途径。
PLoS One. 2013;8(3):e59882. doi: 10.1371/journal.pone.0059882. Epub 2013 Mar 29.